IOL Chemicals

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE485C01029
  • NSEID: IOLCP
  • BSEID: 524164
INR
128.20
3.3 (2.64%)
BSENSE

Jun 18

BSE+NSE Vol: 22.11 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
IOL Chemicals
Advanced Enzyme
RPG LifeScience.
Novartis India
Gufic BioScience
SMS Pharma.
Aarti Drugs
Guj. Themis Bio.
Panacea Biotec
Unichem Labs.
Zota Health Care
Why is IOL Chemicals & Pharmaceuticals Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.01 times
2
Poor long term growth as Net Sales has grown by an annual rate of 1.51% and Operating profit at 1.69% over the last 5 years
3
With a growth in Net Profit of 158.31%, the company declared Very Positive results in Mar 26
  • The company has declared positive results for the last 2 consecutive quarters
  • NET SALES(Q) Highest at Rs 619.45 cr
  • PBDIT(Q) Highest at Rs 92.47 cr.
  • OPERATING PROFIT TO NET SALES(Q) Highest at 14.93%
4
Stock is technically in a Mildly Bullish range
  • The technical trend has improved from Sideways on 28-Apr-26 and has generated 36.38% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and OBV
5
With ROE of 8.1, it has a Very Expensive valuation with a 1.9 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 43.81%, its profits have risen by 44.5% ; the PEG ratio of the company is 0.5
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to IOL Chemicals should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is IOL Chemicals for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
IOL Chemicals
51.0%
0.91
48.15%
Sensex
-4.95%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.51%
EBIT Growth (5y)
1.69%
EBIT to Interest (avg)
10.78
Debt to EBITDA (avg)
0.52
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
1.13
Tax Ratio
25.34%
Dividend Payout Ratio
23.24%
Pledged Shares
0
Institutional Holding
1.74%
ROCE (avg)
9.29%
ROE (avg)
7.92%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
42
Price to Book Value
2.09
EV to EBIT
19.59
EV to EBITDA
13.74
EV to Capital Employed
2.13
EV to Sales
1.59
PEG Ratio
0.58
Dividend Yield
0.78%
ROCE (Latest)
10.90%
ROE (Latest)
8.12%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
NET SALES(Q)

Highest at Rs 619.45 cr

PBDIT(Q)

Highest at Rs 92.47 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 14.93%

PBT LESS OI(Q)

Highest at Rs 68.97 cr.

PAT(Q)

Highest at Rs 53.16 cr.

EPS(Q)

Highest at Rs 1.81

-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 3.85 times

Loading Valuation Snapshot...
Here's what is working for IOL Chemicals
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 68.97 cr has Grown at 89.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 36.35 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 619.45 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 53.16 cr has Grown at 71.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 31.07 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 92.47 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 14.93%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 68.97 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 53.16 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 1.81
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for IOL Chemicals
Debtors Turnover Ratio- Half Yearly
Lowest at 3.85 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio